1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA BNIP1 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA CALML3 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA ZDHHC3 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA KRT82 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA HPDL CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA CYP3A7-CYP3A51P CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA LGALS3 CTRPv2 pan-cancer AAC 0.16 0.0001
mRNA DNAJB4 CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA KIR2DL1 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA C1orf116 CTRPv2 pan-cancer AAC 0.15 0.0001
Download CSV